Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Sywak

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 3, 2019
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinomaKyeong J Kim, Sin G Kim, Jie Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2018
BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid CancerFei Wang, Shihua Zhao, Xiaopei Shen, et al.
Journal of the National Cancer Institute|November 23, 2017
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision TreatmentYueye Huang, Shen Qu, Guangwu Zhu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 7, 2022
Intraoperative MET-receptor targeted fluorescent imaging and spectroscopy for lymph node detection in papillary thyroid cancer: novel diagnostic tools for more selective central lymph node compartment dissectionPascal K C Jonker, Madelon J H Metman, Luc H J Sondorp, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2023
MET-receptor targeted fluorescent imaging and spectroscopy to detect multifocal papillary thyroid cancerMadelon J H Metman, Pascal K C Jonker, Luc H J Sondorp, et al.
The Journal of Clinical Endocrinology and Metabolism|July 17, 2021
BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid CancerYubing Tao, Fei Wang, Xiaopei Shen, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2017
The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid CancerFei Wang, Xiaolong Yu, Xiaopei Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2014
Association between BRAF V600E mutation and recurrence of papillary thyroid cancerMingzhao Xing, Ali S Alzahrani, Kathryn A Carson, et al.
JAMA|April 11, 2013
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancerMingzhao Xing, Ali S Alzahrani, Kathryn A Carson, et al.
Histopathology|January 22, 2024
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinomaYagiz A Aksoy, Bin Xu, Kartik Viswanathan, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|December 3, 2019
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinomaKyeong J Kim, Sin G Kim, Jie Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2018
BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid CancerFei Wang, Shihua Zhao, Xiaopei Shen, et al.
Journal of the National Cancer Institute|November 23, 2017
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision TreatmentYueye Huang, Shen Qu, Guangwu Zhu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 7, 2022
Intraoperative MET-receptor targeted fluorescent imaging and spectroscopy for lymph node detection in papillary thyroid cancer: novel diagnostic tools for more selective central lymph node compartment dissectionPascal K C Jonker, Madelon J H Metman, Luc H J Sondorp, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2023
MET-receptor targeted fluorescent imaging and spectroscopy to detect multifocal papillary thyroid cancerMadelon J H Metman, Pascal K C Jonker, Luc H J Sondorp, et al.
The Journal of Clinical Endocrinology and Metabolism|July 17, 2021
BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid CancerYubing Tao, Fei Wang, Xiaopei Shen, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2017
The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid CancerFei Wang, Xiaolong Yu, Xiaopei Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2014
Association between BRAF V600E mutation and recurrence of papillary thyroid cancerMingzhao Xing, Ali S Alzahrani, Kathryn A Carson, et al.
JAMA|April 11, 2013
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancerMingzhao Xing, Ali S Alzahrani, Kathryn A Carson, et al.
Histopathology|January 22, 2024
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinomaYagiz A Aksoy, Bin Xu, Kartik Viswanathan, et al.
Pageof 10